Clinical Trial News and Research

RSS

Study reveals a promising approach to developing universal influenza vaccine

New research led by Oregon Health & Science University reveals a promising approach to developing a universal influenza vaccine - a so-called "one and done" vaccine that confers lifetime immunity against an evolving virus.

19 Jul 2024

Mobile apps and wearables show promise in easing mental health symptoms during therapy wait times

The recent surge in people seeking mental health care across the country has led to long wait times for first appointments with therapists and psychiatrists.

18 Jul 2024

New drugs show promise in shrinking breast cancer brain metastases

Researchers from Drexel's College of Medicine have identified new drugs that show early success in shrinking breast cancer tumors that have metastasized in the brain.

18 Jul 2024

Improving medication adherence beats resistance testing for better HIV outcomes in African youth

Globally, around 2.6 million children and adolescents are currently living with HIV, the majority of them in Africa.

18 Jul 2024

Harnessing ctDNA measurements for response assessment in metastatic castration resistant prostate cancer

A new editorial paper was published in Oncotarget's Volume 15 on July 2, 2024, entitled, "Using early on-treatment circulating tumor DNA measurements as response assessment in metastatic castration resistant prostate cancer."

18 Jul 2024

Cystic fibrosis drug reduces hyper-inflammation in COVID-19 pneumonia patients

A drug commonly used to treat cystic fibrosis improved outcomes for patients with severe COVID-19 pneumonia and could be used to treat other respiratory infections, according to clinical trial results from researchers at UCL, UCLH and the Francis Crick Institute.

18 Jul 2024

Mindfulness training linked to altered states of consciousness

Mindfulness training may lead participants to experience disembodiment and unity – so-called altered states of consciousness – according to a new study from researchers at the University of Cambridge.

18 Jul 2024

Does reducing leisure-time screen media use improve mental health among children and adolescents?

Researchers investigated whether reducing the use of screen media for leisure improves mental health in adolescents and children.

17 Jul 2024

Nighttime resistance exercise 'activity breaks' may boost sleep duration, study finds

Resistance exercise 'activity breaks' at night may improve sleep length, suggest the findings of a small comparative study published in the open access journal BMJ Open Sport & Exercise Medicine.

17 Jul 2024

UCLA investigators receive $800,000 grant to treat and prevent aggressive kidney cancer

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have received an $800,000 grant from the V Foundation to find new ways to treat and prevent a severe form of kidney cancer associated with a hereditary syndrome caused by mutations in the fumarate hydratase (FH) gene.

16 Jul 2024

UIC researchers explore digital tools to personalize depression treatment

New research at the University of Illinois Chicago is testing whether digital tools can help predict which patients with depression will benefit from specific treatments and help deliver those treatments to them on demand.

16 Jul 2024

Researchers identify ORF6 protein as key to SARS-CoV-2 immune evasion

An article published in the journal Cell describes a study that enabled a group of researchers to discover how SARS-CoV-2 evades the cytotoxic immune response by identifying a protein called ORF6 that is a key factor in this mechanism.

16 Jul 2024

Daily supplement may help preserve vision in people with late-stage dry AMD

In a new analysis of data, researchers at the National Institutes of Health (NIH) have found that taking a daily supplement containing antioxidant vitamins and minerals slows progression of late-stage dry age-related macular degeneration (AMD), potentially helping people with late-stage disease preserve their central vision.

16 Jul 2024

Early detection of specific microRNAs may help predict preeclampsia in pregnant women

Preeclampsia (PE) is a significant contributor to the increase in maternal morbidity and mortality worldwide, with particularly alarming numbers in the United States, where it affects about 2–8% of pregnancies, resulting in premature birth with associated morbidities for their infants as well.

16 Jul 2024

UChicago expands microbiome research capabilities with new manufacturing facility

The Duchossois Family Institute (DFI) at the University of Chicago can manufacture clinical-grade encapsulated bacteria – catalyzing opportunities to better understand the microbiome and its myriad of roles in human health.

16 Jul 2024

Triad of immune cells key to successful cancer immunotherapy, study finds

There's a frustrating fact about today's immunotherapies for cancer. While sometimes they work beautifully - completely eliminating or greatly reducing cancer in particular patients - other times they don't work at all. It's a mystery.

15 Jul 2024

Cannabigerol shows promise in reducing anxiety and enhancing memory without side effects

Researchers at Washington State University found that cannabigerol (CBG) reduces anxiety and improves verbal memory without causing intoxication or impairments in healthy adults.

15 Jul 2024

Enhancing family-based treatment for anorexia nervosa: The role of intensive parental coaching

A study opens in new tab/window in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP)opens in new tab/window, published by Elsevier, investigated adaptive treatment for Anorexia Nervosa (AN), a serious psychiatric disorder with high morbidity and mortality.

15 Jul 2024

Consumer wearable devices provide clinical information similar to hospital assessment of heart disease

Monitoring of heart rate and physical activity using consumer wearable devices was found to have clinical value for comparing the response to two treatments for atrial fibrillation and heart failure.

15 Jul 2024

Long-term, 30-year CVD risk may help inform therapy for stage 1 hypertension

A comparison of two risk prediction tools used to calculate an individual's risk of developing cardiovascular disease (CVD) suggests that the long-term, 30-year risk should be considered in addition to the short-term, 10-year risk to help inform when to begin medication therapy for stage 1 hypertension, or high blood pressure, according to new research published today in Hypertension, an American Heart Association journal.

15 Jul 2024

Clinical Trial News and Research

Study reveals a promising approach to developing universal influenza vaccine

Mobile apps and wearables show promise in easing mental health symptoms during therapy wait times

New drugs show promise in shrinking breast cancer brain metastases

Improving medication adherence beats resistance testing for better HIV outcomes in African youth

Harnessing ctDNA measurements for response assessment in metastatic castration resistant prostate cancer

Cystic fibrosis drug reduces hyper-inflammation in COVID-19 pneumonia patients

Mindfulness training linked to altered states of consciousness

Does reducing leisure-time screen media use improve mental health among children and adolescents?

Nighttime resistance exercise 'activity breaks' may boost sleep duration, study finds

UCLA investigators receive $800,000 grant to treat and prevent aggressive kidney cancer

UIC researchers explore digital tools to personalize depression treatment

Researchers identify ORF6 protein as key to SARS-CoV-2 immune evasion

Daily supplement may help preserve vision in people with late-stage dry AMD

Early detection of specific microRNAs may help predict preeclampsia in pregnant women

UChicago expands microbiome research capabilities with new manufacturing facility

Triad of immune cells key to successful cancer immunotherapy, study finds

Cannabigerol shows promise in reducing anxiety and enhancing memory without side effects

Enhancing family-based treatment for anorexia nervosa: The role of intensive parental coaching

Consumer wearable devices provide clinical information similar to hospital assessment of heart disease

Long-term, 30-year CVD risk may help inform therapy for stage 1 hypertension

eBook: Using iPSCs models for human disease research and drug discovery eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer